DeepTek introduces new Al powered lumbar spine quantification automation tool

India-based health tech startup DeepTek has announced the global launch of DeepSpine - an artificial intelligence (AI) powered lumbar spine quantification and metrics tool designed to analyse MRI lumbar spine images.

Moderna buys Japanese startup OriCiro for $85M

OriCiro Genomics, founded in December 2018, is focussed on the development and commercialisation of cellfree synthesis

China's ReLive Biotechnologies strengthens presence in regenerative therapy market

Simultaneously with the acquisition, ReLive also completed its Series A financing of $36 million to fund the company’s global ambition.

Seno Medical enters exclusive distributor agreement with Genetik

Seno Medical, based in the US, has entered into an exclusive distributor agreement with Genetik, to market, sell and service the company’s groundbreaking Imagio Opto-Acoustic/ Ultrasound (OA/US) Breast Imaging System.

Malaysian Genomics explores R&D collaboration with SIRIM

Under the strategic cooperation, both parties will evaluate the potential commercial value of a range of genomicsdriven biotechnology R&D projects.

Terumo and Siemens Healthineers collaborate to strengthen cardiac care in India

The collaboration will flag off its efforts with a customised training programme for Cathlab professionals, being developed in partnership with an eminent academic institute in India.

Aculys Pharma, Four H initiate collaboration using wearable devices to study sleep disorders in Japan

In its quest to establish a new pharmaceutical model, Aculys is promoting DX (digital transformation) in clinical trials and medicine.

Lotte Biologics announces $3 B investment plan to leap forward as global CDMO

Lotte Biologics CEO Richard Wonjik Lee has announced a blueprint to leap forward as a global contract development and manufacturing organisation (CDMO).

Sun Pharma buys US-based Concert Pharma for $576 M

Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the US Food and Drug Administration (FDA) in the first half of 2023.

SK bioscience's shingles vaccine receives biologics license application approval in Malaysia

SKYZoster is shown clinically acceptable immunogenicity and safety at Phase III clinical trial.

Mobile app to help adolescents access public health services in Bangladesh

Millions of adolescents and youth in Bangladesh will be able to access health information and services through two online portals launched recently at The National Adolescent Health Conference held in Dhaka.

New Zealand approves new therapy to treat rare gastrointestinal stromal tumour

Specialised Therapeutics Asia (ST), based in Singapore, has announced that a new therapy to treat rare gastrointestinal stromal tumour (GIST) shown to improve survival has now been approved in New Zealand.

Indonesia's TB response gets $300 M programme World Bank loan

The World Bank’s Board of Executive Directors has approved a $300 million loan to the Indonesian government to improve coverage, quality and efficiency of tuberculosis (TB) response in Indonesia.

Too Much Of A Good Thing...

Thinking long term to ensure that huge amounts of vaccines are not wasted, manufacturers need to have a far-sightedness and not just go on a production spree.

Life Sciences Trends To Watch For In 2023

The past two years have been a rollercoaster ride for the global economy and the pharma industry hasn't been impervious to the major financial upheavals either.

HTAs, CGT Set to Rule Life Sciences Industry in 2023

overnments and other payers make decisions ee the context of the broader economic environment. For 2023 we will continue to see the impact of these global economic trends on payer decisions as they increase financial pressure in the APAC region.

XtalPi joins hands with Singapore’s EDDC

For cancer drug discovery

IVI, ST Pharm exchange MoU,

clinical development of COVID-19 vaccine

Pharmaniaga strives to develop children’s hexavalent vaccine by 2023

Pharmaniaga LifeScience Sdn Bhd PLS), a wholly-owned subsidiary of Malaysia’s leading pharmaceutical company

Alliance Pharma unveils state-of-the-art

bioanalytical lab in Brisbane

Vaxxas raises A$34M to clinicall advance needle-free vaccines

Vaxxas has completed a financing round which raised 23 million A$34 million) in new funds.

Merck, Kelun-Biotech ink $9.3B licensing pact for 7 cancer candidates in China

news about finance

Prejex joins hands with Polybond to make needle-less injections in India

Prejex Inc., a spin-off of Germany-based Prejex GMBH, has entered into an agreement with Polybond, headed by Adit Rathi of Rathi Group to manufacture needleless injections.

Thailand develops

speech recognition AI tech for screening depression

Australian first research

trial to explore use of psychedelics for alcohol use disorder

AstraZeneca India

appoints Dr Sanjeev Panchal as Country President MD

One Health Trust BITS Pilani offer PhD

programme in Data Sciences for global health

NTU Singapore and Imperial College London strengthen ties

Building on their successful collaboration in setting up the Lee Kong Chian School of Medicine LKCMedicine), Nanyang Technological University, Singapore NTU Singapore) and Imperial College London have signed a new strategic university-wide partnership to expand their scope of collaboration across research, education, and innovation and enterprise.

Broad-impact Tech Against AMR Threat

According to one of the most comprehensive studies of antimicrobial resistance AMR), 95 million deaths were associated with including 1.27 million deaths attributed to bacterial AMR in 20109.

Al: Tremendous Potential to Transform Bioprocessing Efficiencies

The biopharmaceutical industry is witnessing unprecedented growth, with a surge in demand for vaccines, monoclonal antibodies mAbs), and advanced modalities including RNA therapeutics, mRNA vaccines, and cell and gene therapies CGTs).